Onto Innovation vs Revolution Medicines Inc. Common Stock — how do they compare? Onto Innovation trades at $294.2 (market cap $14.36B), while Revolution Medicines Inc. Common Stock trades at $189.32 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 2.8× Onto Innovation's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, Onto Innovation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Onto Innovation for 6 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| ONTO | RVMD | |
|---|---|---|
Market Cap | $14.36B | $40.32B |
Volume | 761,617 | 4,855,734 |
Sector | Technology | Health |
52-Week High | $378.45 | $221.15 |
52-Week Low | $121.34 | $47.50 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $13.95B | $37.02B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Onto Innovation provides process control solutions for semiconductor manufacturing. Its inspection and metrology systems help chipmakers measure, analyze, and detect defects on wafers and advanced packages.
Read more on ONTO →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →